101 related articles for article (PubMed ID: 23149704)
21. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop.
Swerdlow SH; Quintanilla-Martinez L; Willemze R; Kinney MC
Am J Clin Pathol; 2013 Apr; 139(4):515-35. PubMed ID: 23525619
[TBL] [Abstract][Full Text] [Related]
23. Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Suh C; Kim HJ
Cancer Sci; 2010 Nov; 101(11):2443-7. PubMed ID: 20831770
[TBL] [Abstract][Full Text] [Related]
24. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.
Edinger JT; Kant JA; Swerdlow SH
Am J Surg Pathol; 2010 Dec; 34(12):1830-41. PubMed ID: 21107089
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous B-cell lymphomas. Current concepts. I.
Santucci M; Pimpinelli N
Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
[TBL] [Abstract][Full Text] [Related]
27. [Marginal zone B-cell lymphoma affecting the skin: histological and phenotypic study of 49 cases].
Bathelier E; Thomas L; Balme B; Coiffier B; Berger F; Ffrench M; Salles G; Dalle S
Ann Dermatol Venereol; 2008 Nov; 135(11):748-52. PubMed ID: 19061653
[TBL] [Abstract][Full Text] [Related]
28. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
29. [Febrile cellulitis surrounding a scar revealing a large immunoblastic B-cell lymphoma].
Charavin-Cocuzza M; Templier I; Simon A; Salameire D; Cuchet E; Reymond JL; Beani JC; Leccia MT
Ann Dermatol Venereol; 2008 Dec; 135(12):848-51. PubMed ID: 19084696
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccination.
May SA; Netto G; Domiati-Saad R; Kasper C
J Am Acad Dermatol; 2005 Sep; 53(3):512-6. PubMed ID: 16112365
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal.
Magro CM; Kalomeris T; Roberts A
Ann Diagn Pathol; 2023 Apr; 63():152101. PubMed ID: 36634549
[TBL] [Abstract][Full Text] [Related]
33. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous marginal zone B-cell lymphoma: a report of 9 cases.
de la Fouchardière A; Balme B; Chouvet B; Sebban C; Perrot H; Claudy A; Bryon PA; Coiffier B; Berger F
J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):181-8. PubMed ID: 10426886
[TBL] [Abstract][Full Text] [Related]
35. Extranodal lymphomas: the MALT concept.
Isaacson PG
Verh Dtsch Ges Pathol; 1992; 76():14-23. PubMed ID: 1283245
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
Vermeer MH; Geelen FA; van Haselen CW; van Voorst Vader PC; Geerts ML; van Vloten WA; Willemze R
Arch Dermatol; 1996 Nov; 132(11):1304-8. PubMed ID: 8915307
[TBL] [Abstract][Full Text] [Related]
37. CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11).
Mian M; Marcheselli L; Luminari S; Federico M; Cantonetti M; Sarris AH; Rossi A; Rambaldi A; Frontani M; Devizzi L; Gianni AM; Busetto M; Berti E; Martinelli G; Tsang RW; Ferreri AJ; Pinotti G; Pogliani E; Zucca E; Cortelazzo S
Ann Hematol; 2011 Apr; 90(4):401-8. PubMed ID: 20872000
[TBL] [Abstract][Full Text] [Related]
38. Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab.
Morales AV; Advani R; Horwitz SM; Riaz N; Reddy S; Hoppe RT; Kim YH
J Am Acad Dermatol; 2008 Dec; 59(6):953-7. PubMed ID: 18817999
[TBL] [Abstract][Full Text] [Related]
39. Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.
Tam CS; Prince HM; Westerman D; Seymour JF; Juneja S
Leuk Lymphoma; 2004 Apr; 45(4):705-10. PubMed ID: 15160943
[TBL] [Abstract][Full Text] [Related]
40. Expression of germinal center cell markers by extranodal marginal zone lymphomas of MALT type within colonized follicles, a diagnostic pitfall with follicular lymphoma.
Poveda J; Cassidy DP; Zhou Y; Alderuccio JP; Lossos IS; Vega F; Chapman J
Leuk Lymphoma; 2021 May; 62(5):1116-1122. PubMed ID: 33283568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
